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Abstract
Background: It has been reported that prolonged intensive care unit (ICU) stay after cardiac surgery is associated
with poor patient outcome. In addition, prolonged stay can block the efficient use of ICU beds with an increase in
expenditure of
health-care costs. The aim of the present study was to retrospectively determine which pre- and intra-operative
factors could significantly affect ICU-free survival days (IFSD) which has been suggested to reflect postoperative
patients’ outcome, as well as variables significantly associated with the main predictors of IFSD.
Findings: We reviewed anesthesia charts and medical records of 145 patients undergoing cardiac surgery under
cardiopulmonary bypass (CPB) in our hospital from January 2014 to October 2015, and 72 patients’ records were
finally used for the analysis. IFSD was a median of 25 days (95% CI 24–26). The multiple regression analysis
indicated that preoperative estimated glomerular filtration
rate, differences between preoperative mean arterial pressure and mean CPB pressure, and blood lactate level at
2 h after CPB (CPB-2 h) were independently associated with IFSD (β regression coefficients 0.086, −0.083, and −3.
601, respectively).
Conclusion: In addition to preoperative renal function and differences between preoperative MAP and CPB
pressure, the lactate level at CPB-2 h could be a major predictor of postoperative outcome in patients undergoing
cardiac surgery.
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Findings
Background
It has been reported that prolonged intensive care unit
(ICU) stay after cardiac surgery is associated with poor
patient outcome [1, 2]. As prolonged ICU stay has also
been reported to cause a significant decrease in long-
term survival, determination of risk factors related to the
prolonged ICU stay may be helpful to improve patients’
outcome by avoiding these risk factors. In addition, pro-
longed stay can block the efficient use of ICU beds, may
result in postponement of other operations, and also
increases expenditure of health-care costs [1, 2]. The use
of life-support equipments such as ventilator and renal
replacement system can particularly cause excessive
expenditure in the ICU [3].
When patients die in a short period in the ICU, length
of ICU stay (LOS) becomes shorter. Thus, as the LOS
may not reflect patient’s prognosis and severity of an ill-
ness, “ICU-free survival days” is now widely used as a
better index than LOS for the outcome study [4, 5].
The aim of the present study was to retrospectively
determine which pre- and intra-operative factors could
significantly affect ICU-free survival days.
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This is a retrospective observational study approved by the
Medical Ethics Committee of Hirosaki University Graduate
School of Medicine (approval number 2015-168). There
were 145 patients undergoing elective cardiac surgery
under CPB in our institution between January 2014 and
October 2015. As the following patients were excluded:
patients under 18 years old, receiving on-pump beating
procedure or circulatory arrest, and with CPB duration less
than 120 min, 72 patients’ records were finally used for the
analysis.
Anesthesia and CPB management
Anesthesia was induced and maintained using total
intravenous anesthesia with propofol 1–5 mg/kg/h, keta-
mine 0.5–2 mg/kg/h, fentanyl 15–25 μg/kg, and inter-
mittent 10 mg rocuronium in all cases. After tracheal
intubation, the lungs were ventilated with intermittent
positive-pressure ventilation under FIO2 of 0.3 to 1
which was dependent on oxygenation status. Vasoactive
agents and inotropics were administrated to maintain
stable hemodynamics when needed. The whole-blood
activated coagulation time (ACT) was maintained
greater than 400 s with intermittent intravenous heparin
administration during CPB. The CPB circuit was primed
with colloid solutions at variable volumes. Cold
crystalloid cardioplegia was administrated in an ante-
grade fashion every 30 min during the cross-clamping
period or whenever electrical activity resumed. During
CPB, the following conditions were maintained: a mild
hypothermia of 32–34 °C, nonpulsatile flow at 2.2–
2.6 L/min/m2, mean perfusion pressure of 60–70 mmHg,
and hematocrit (Hct) >22%. To keep target mean perfu-
sion pressure during CPB, vasopressor administration
and/or increasing perfusion flow were performed. At the
end of CPB, protamine was administrated as required to
return the ACT to the baseline values. Intra-operative
blood salvage was also performed in most cases.
Data collection and definitions
The following available data were collected from each pa-
tient’s record: age, sex, body weight, height, comorbidity
(hypertension, diabetes, kidney injury, cerebrovascular
diseases), current smoking and history of cardiac surgery,
preoperative estimated glomerular filtration rate (eGFR),
preoperative serum brain natriuretic peptide, New York
Heart Association class, left ventricular ejection fraction
(%) estimated by echo-cardiography or angiography, type of
operation, CPB data (CPB duration, aortic cross-clamping
duration, nadir Hct, nadir temperature, perfusion pressure,
mean flow), blood transfusions, preoperative vasoactive
medication, LOS, and postoperative morbidity and mortal-
ity. Postoperative morbidity was defined as the following:
renal complications (more than “injury” of RIFLE criteria
for acute kidney injury (AKI)); respiratory complications
(mechanical ventilation longer than 24 h with no apparent
cardiac reason, requirement of noninvasive positive pres-
sure ventilation or high-flow nasal cannula after tracheal
extubation, acute respiratory distress syndrome); neurologic
complications (coma or new focal neurologic deficit) [6];
cardiovascular complications (cardiac arrest, the require-
ment of percutaneous cardiopulmonary support (PCPS));
and requirement of surgical hemostasis. Blood lactate was
measured by an arterial blood gas analyzer (ABL 800, Radi-
ometer Co., Copenhagen, Denmark). After CPB was
started, blood lactate was measured every 1 h. Average
mean arterial pressure (MAP) was obtained from three pre-
operative blood pressure readings: on admission, in the day
before surgery, and just before induction of general
anesthesia was defined as baseline MAP [7]. Mean CPB
pressure and flow were also defined as the average of MAP
and flow reading at every 30 min during CPB. Ratio of
<CPB 60 or 50 mmHg was defined as the rate of the dur-
ation lower than 60 or 50 mmHg during CPB. ICU-free
survival days was determined as the reminder to subtract
LOS from 28 days. The criteria of ICU stay for post-cardiac
surgical patients were the following: unstable respiration
without any respiratory assist, using vasopressors, or need-
ing renal replacement therapy. The discharge criteria of
ICU were the following: stable respiration without
orotracheal tube and maintaining SpO2 >92% without non-
invasive positive pressure, stable circulation with no re-
quirement of hemodynamic monitoring and maintaining
systolic blood pressure >90 mmHg without vasoactive
agents, and no requirement of compensation of acute
abnormal laboratory values.
Outcome and statistical analyses
To determine which pre- and intra-operative factors could
affect the ICU-free survival days, we performed univariate
analysis to find candidate factors (p < 0.05) and then did
multivariate regression analysis (SPSS 24.0, SPSS Inc., Chi-
cago, IL, USA) by stepwise method. Data are presented as
regression coefficient with 95% confidence intervals (CI).
Other data were shown as median [25% quartile–75%
quartile] or n (%). A p < 0.05 was considered statistically
significant.
Results
Preoperative and intra-operative demographics are depicted
in Tables 1 and 2, respectively. ICU-free survival days in
our study was a median of 25 days (95% CI 24–26). There
were 19 patients (26.4%) who had at least one postoperative
complications, 3 patients with renal complications, 12 pa-
tients with respiratory complications, 2 patients with
neurologic complications, 3 patients with cardiovascular
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complications, and 4 patients required surgical hemostasis.
And there were two patients (2.8%) who had died in ICU.
The univariate analysis indicated that ICU-free survival
days could significantly be associated with preoperative
eGFR, CPB duration, differences between preoperative
MAP and mean CPB pressure, and blood lactate level mea-
sured 2 h after CPB started (CPB-2 h) (Table 3).
In our multivariate linear regression model including
possible confounders, preoperative eGFR, differences be-
tween preoperative MAP and mean CPB pressure, and
blood lactate level at 2 h after CPB were independently
associated with ICU-free survival days (Table 4).
Discussion
Our retrospective analysis suggests that preoperative
eGFR, differences between preoperative MAP and mean
CPB pressure, and blood lactate level at CPB-2 h were
associated with ICU-free survival days in the multivari-
ate analysis.
The increase in blood lactate during CPB is well known
in patients undergoing cardiac surgery due to variable rea-
sons such as peripheral circulatory failure, hemodilution, or
using catecholamine [8–10]. In addition, high blood lactate
levels during perioperative period have been reported to be
associated with worse outcomes including mortality [9–17].
Previous studies showed that early postoperative hyperlac-
tatemia was more sensitive predictor of mortality and mor-
bidity for patient undergoing cardiac surgery under CPB
than late hyperlactatemia during ICU stay [10, 18]. It was
also reported that the maximum lactate level during cardiac
surgery after CPB was significantly associated with LOS [9]
and ICU-free survival days [19]. Early postoperative hyper-
lactatemia was associated with a low oxygen delivery during
CPB [9–12]. Thus, the proper managements of CPB could
avoid the increase in blood lactate levels. Although previous
studies showed that the highest lactate level during CPB, its
level at the end of CPB, or its level at the postoperative
period could be related to worse postoperative outcomes,
there is no report showing that lactate level at some time
point during CPB could be the predictor of postoperative
impaired outcome. In this regard, the present study may be
the first report. In addition, the present data suggest that
early therapeutic intervention in accordance with blood lac-
tate levels during CPB might be important to avoid worth
Table 1 Preoperative patient demographics
Variable Data
Age (years) 66.5 [60.5–73.0]
Weight (kg) 53.2 [48.0–60.3]
Body mass index (kg/m2) 22.3 [20.2–23.6]
Body surface area (m2) 1.52 [1.43–1.63]
Gender: male (%) 34 (47.2)
Hypertension (%) 49 (68.0)
Diabetes (%) 12 (16.7)
Dyslipidemia (%) 26 (36.1)
Current smoking (%) 29 (40.3)
Previous stroke (%) 18 (25.0)
Chronic dialysis (%) 9 (12.5)
Previous cardiac surgery (%) 8 (11.1)
Preoperative eGFR (ml/min/1.73 m2) 54.1 [44.1–69.1]
Preoperative BNP (pg/ml) 253 [87–496]
NYHA class I/II/III/IV 16/45/10/1
Left ventricular ejection fraction (%) 61.5 [50.7–70.6]
Preoperative systolic blood pressure (mmHg) 131 [116–141]
Preoperative diastolic blood pressure (mmHg) 68 [60–76]
Preoperative mean arterial pressure (mmHg) 87 [82–97]
Preoperative β-blocker (%) 19 (26.4)
Preoperative anticoagulant (%) 29 (40.3)
Preoperative antiplatelet drug (%) 12 (16.7)
Type of operation
Single valve surgery (%) 43 (59.7)
Complex valve surgery (%) 16 (22.2)
CABG and valve surgery (%) 9 (12.5)
Other (%) 4 (5.6)
Data were shown as median [25% quartile–75% quartile] or n (%)
eGFR estimated glomerular filtration rate, BNP brain natriuretic peptide, NYHA
New York Heart Association
Table 2 Intra-operative characteristics
Variable Data
CPB duration (min) 198 [167–232]
Aortic cross-clamping duration (min) 133 [112–161]
Nadir hematocrit on CPB (%) 24.1 [20.5–27.8]
Nadir temperature on CPB (°C) 34.0 [33.0–34.4]
Mean CPB pressure (mmHg) 55.0 [49.7–60.5]
Ratio of <CPB pressure 60 mmHg (%) 65.7 [40.0–89.9]
Ratio of <CPB pressure 50 mmHg (%) 26.0 [9.2–47.6]
Preoperative MAP—mean CPB pressure 32.0 [12.7–51.3]
Mean CPB flow (L/min) 3.77 [3.48–4.13]
Mean CPB flow index (L/min/m2) 2.49 [2.41–2.55]
Vasopressors during CPB (%) 23 (31.9)
Transfusions during CPB with RBCs (%) 26 (36.1)
Transfusions during CPB with FFPs (%) 20 (27.8)
Lactate level at CPB-0 h (mmol/L) 0.8 [0.6–1.0]
Lactate level at CPB-1 h (mmol/L) 1.1 [0.8–1.4]
Lactate level at CPB-2 h (mmol/L) 1.3 [1.0–1.7]
Data were median [25% quartile–75% quartile] or n (%), ratio of <CPB pressure
**mmHg (%): (duration of lower than **mmHg during CPB/total
CPB time) × 100
CPB cardiopulmonary bypass, MAP mean arterial pressure, CPB-#h # h after
CPB started
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postoperative outcome rather than therapeutic intervention
after CPB or during ICU stay.
In the present study, difference between preoperative
MAP and mean CPB perfusion pressure was also signifi-
cantly associated with ICU-free survival days. A previous
study suggested that a drop in MAP by more than
26 mmHg from preoperative blood pressure caused a 2.8-
fold increase in a risk of development of postoperative AKI
[7]. It is likely that the patients with development of AKI
stay in the ICU longer than those without AKI. The
maintenance of adequate perfusion pressure during CPB is
important for vital organ perfusion [19]. It has been sug-
gested that relatively high perfusion pressure during CPB is
preferable to prevent cerebrovascular and gastroentero-
logical complications, especially in the patients with im-
paired autoregulation system due to arteriosclerosis [13].
Even if autoregulation system well regulates to maintain
peripheral tissue circulation, CPB perfusion pressure seems
to be more important to prevent peripheral tissue hypoper-
fusion under nonpulsatile flow. Recently, study suggested
that not only high perfusion flow but also high perfusion
pressure was necessary during CPB to protect the skeletal
muscle [20]. It remains controversial which is more import-
ant for management of CPB, pressure, or flow. However,
the present study clearly demonstrates that it may be neces-
sary to minimize the difference preoperative MAP and CPB
perfusion pressure. Further study will be required to deter-
mine the cutoff point between them for postoperative
morbidity.
Preoperative renal function also independently contrib-
utes to ICU-free survival days. A previous study suggested
that preoperative serum creatinine was a predictor for post-
operative renal complications and in-hospital mortality in
patient undergoing cardiac surgery [6, 21]. In addition, it
has also suggested that CPB duration would prolong in pa-
tients with preoperative renal insufficiency [6, 21]. As pa-
tients requiring hemodialysis particularly have multiple
comorbidities such as hypertension, angina pectoris,
diabetes, hyperlipidemia, and cerebrovascular diseases with
severe arteriosclerosis, these patients would need prolonga-
tion of CPB and extended ICU stay. Therefore, we also
have to pay careful attention to preoperative renal function
in cardiac surgical patients.
Mean ICU-free survival days in present study was 25 days
in our institution. Furushima and colleagues [14] reported
that maximum lactate levels measured after CPB was inde-
pendently associated with ICU-free survival days. And
other study also suggested that postoperative maximum
lactate levels could be the predictors about cardiac surgical
morbidity and mortality. Demers and colleagues [9] showed
that the patient with peak intra-operative blood lactate
levels higher than 4.0 mmol/L needed prolonged ICU stay
Table 3 Univariate association of preoperative and intra-




Gender: male −0.397 [−2.608 to 1.741] 0.692
Age −0.028 [−0.191 to 0.055] 0.813
Body mass index −0.216 [−0.426 to 0.0169] 0.069
Hypertension 0.738 [−1.463 to 3.181] 0.463
Diabetes −0.114 [−3.083 to 2.749] 0.910
Dyslipidemia −0.059 [−2.330 to 2.196] 0.953
Previous stroke 0.649 [−1.688 to 3.318] 0.518
Current smoking −1.411 [−3.734 to 0.639] 0.163
Previous cardiac surgery −0.415 [−4.173 to 2.736] 0.679
Chronic dialysis 1.940 [−1.279 to 14.99] 0.088
Preoperative eGFR 0.074 [0.036 to 0.111] <0.001*
Preoperative BNP −0.068 [−0.469 to 0.046] 0.568
Left ventricular ejection fraction 0.177 [−0.120 to 0.494] 0.137
Preoperative anticoagulant −0.719 [−3.004 to 1.413] 0.475
Valve surgery 0.620 [−3.262 to 6.203] 0.537
CPB duration −0.260 [−0.538 to −0.147] 0.028*
Aortic cross-clamping duration −0.109 [−0.419 to 0.067] 0.361
Nadir hematocrit 0.179 [−0.061 to 0.321] 0.133
Mean CPB pressure 0.042 [−0.211 to 0.201] 0.727
Ratio of <CPB pressure 60 mmHg −0.184 [−0.350 to 0.144] 0.123
Ratio of <CPB pressure 50 mmHg −0.057 [−0.269 to 0.174] 0.636
Preoperative MAP—mean CPB
pressure
−0.235 [−0.427 t6 0.172] 0.047*
Mean CPB flow index −0.190 [−0.455 to 0.115] 0.110
Vasopressors during CPB −0.134 [−2.487 to 2.175] 0.894
Transfusions during CPB with
RBCs
1.800 [−0.332 to 5.195] 0.082
Lactate level at CPB-0 h −0.094 [−0.298 to 0.070] 0.431
Lactate level at CPB-1 h −2.120 [−4.566 to 0.327] 0.088
Lactate level at CPB-2 h −2.646 [−4.455 to −0.837] 0.005*
Data were shown as regression coefficients with 95% confidence intervals
(CIs), ratio of <CPB pressure **mmHg (%): (duration of lower than **mmHg
during CPB/total CPB time) × 100
eGFR estimated glomerular filtration rate, BNP brain natriuretic peptide, CPB
cardiopulmonary bypass, MAP mean arterial pressure, CPB-#h # h after CPB started
*p < 0.05
Table 4 Multivariate association of preoperative and intra-operative
variables with the ICU-free survival days
Variable Regression coefficient p value
Preoperative eGFR 0.086 <0.001*
CPB duration −0.107 0.278
Preoperative MAP—mean CPB pressure −0.083 0.015*
Lactate level at CPB-2 h −3.601 <0.001*
Model R2 = 0.387; data were shown as β regression coefficients
CPB cardiopulmonary bypass, MAP mean arterial pressure, CPB-#h # h after CPB
started, eGFR estimated glomerular filtration rate
*p < 0.05
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longer than 5 days. Maillet and colleagues [10] suggested
that blood lactate level of 3 mmol/L at ICU admission
could indicate high risk of postoperative morbidity and
mortality in cardiac surgical patients. In addition, they
showed that the LOS was 3.8 days in early hyperlactatemia
group and 1.9 days in normal lactate range group. Com-
pared to ICU-free survival days calculated from the LOS in
the previous reports, the present data were slightly differ-
ent. This small discrepancy might be due to the difference
in the ICU discharge criteria between each institution.
Other pre- or intra-operative predictors for cardiac surgical
morbidity were reported as follows: emergency case, re-
operation, preoperative low cardiac output, and prolonged
CPB duration [2, 6]. In the present study, although
emergency cases were excluded for the analysis, re-
operation (p = 0.679 by univariate analysis), preoperative
low cardiac output (p = 0.137 by univariate analysis), and
CPB duration (p = 0.028 by univariate analysis but p = 0.278
by multivariate regression analysis) were not recognized as
significant. Therefore, although CPB duration might be-
come significant with much larger sample size, others
would not be predictors for postoperative morbidity and
mortality in cardiac surgical patients.
The sample size of this study was small, but we per-
formed post hoc analysis and the power of this study was
0.88 (n = 72, α = 0.05, r = −0.31, correlated regression be-
tween ICU-free survival days and lactate level measured
2 h after CPB). Therefore, we believe that the present data
must be meaningful.
In conclusion, in addition to preoperative renal function
and differences between preoperative MAP and CPB pres-
sure, the lactate level at CPB-2 h could be a predictor of
ICU-free survival days in patients undergoing cardiac
surgery.
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